is semaglutide in short supply Troubling Findings Study of GLP-1 Compounders Why Low Cost Weight Loss

"Weight loss is a side effect for both medicines, but Ozempic has a bigger effect," Ponder says

The FDA label states that providers should consider discontinuing treatment if patients do not achieve at least 5% weight loss after 12 weeks at the maintenance dose, as continued use is unlikely to provide meaningful clinical benefit

Lab work helps establish your baseline health and checks for any red flags that could make GLP-1s unsafe

While the development of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has expanded diabetes care, the bulk of the literature on these medications derives from tightly controlled clinical trials (e.g., Phase III trials such as the global PIONEER program), with only a few studies investigating their real-world effectiveness